Login / Signup

Biosignature stability in space enables their use for life detection on Mars.

Mickael BaquéTheresa BackhausJoachim MeeßenFranziska HankeUte BöttgerNisha RamkissoonKaren Olsson-FrancisMichael BaumgärtnerDaniela BilliAlessia CassaroRosa de la Torre NoetzelRené DemetsHowell EdwardsPascale EhrenfreundAndreas ElsaesserBernard FoingFrederic FoucherBjörn HuweJasmin JoshiNatalia O KozyrovskaPeter LaschNatuschka M LeeStefan LeukoSilvano OnofriSieglinde OttClaudia PacelliElke RabbowLynn J RothschildDirk Schulze-MakuchLaura SelbmannPaloma SerranoUlrich SzewzykCyprien VerseuxDirk WagnerFrances WestallLaura ZucconiJean-Pierre Paul de Vera
Published in: Science advances (2022)
Two rover missions to Mars aim to detect biomolecules as a sign of extinct or extant life with, among other instruments, Raman spectrometers. However, there are many unknowns about the stability of Raman-detectable biomolecules in the martian environment, clouding the interpretation of the results. To quantify Raman-detectable biomolecule stability, we exposed seven biomolecules for 469 days to a simulated martian environment outside the International Space Station. Ultraviolet radiation (UVR) strongly changed the Raman spectra signals, but only minor change was observed when samples were shielded from UVR. These findings provide support for Mars mission operations searching for biosignatures in the subsurface. This experiment demonstrates the detectability of biomolecules by Raman spectroscopy in Mars regolith analogs after space exposure and lays the groundwork for a consolidated space-proven database of spectroscopy biosignatures in targeted environments.
Keyphrases
  • raman spectroscopy
  • label free
  • radiation therapy
  • cancer therapy
  • emergency department
  • drug delivery
  • density functional theory
  • drug induced